At Balaxi, our business strategies are responsible for creating a portfolio of valuable pharmaceutical products and taking them to diverse geographies across the world. We generally look for markets based out of non-English speaking countries with improving GDP per capita.
We undertake proprietary market research and assess the demand for various products in our target markets. In addition to this, we file technical dossier for product registrations in these potential markets. We are backed by a well-established expert regulatory team, which carefully monitors the registration process at every stage.
As of today, we have 548 valid pharmaceutical product registrations across different countries in the world. Our aim is to double our portfolio of product registrations over the next two years.